We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$8.36B
AUM Growth
-$501M
Cap. Flow
-$840M
Cap. Flow %
-10.05%
Top 10 Hldgs %
55.3%
Holding
88
New
16
Increased
20
Reduced
17
Closed
12

Top Buys

Rank Stock Value
1
VST icon
Vistra
VST
+$364M
2
CEG icon
Constellation Energy
CEG
+$243M
3
VTRS icon
Viatris
VTRS
+$109M
4
AKAM icon
Akamai
AKAM
+$98.7M
5
PRMB
Primo Brands
PRMB
+$67.1M

Top Sells

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$217M
2
BAX icon
Baxter International
BAX
+$86M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$81.2M
4
ARQT icon
Arcutis Biotherapeutics
ARQT
+$63.4M
5
COLL icon
Collegium Pharmaceutical
COLL
+$55.6M

Sector Composition

Rank Sector Weight
1 Healthcare 33.3%
2 Utilities 26.27%
3 Industrials 14.79%
4 Energy 5.36%
5 Financials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SDGR icon
26
Schrodinger
SDGR
$1.4B
$74.6M 0.89%
4,171,498
-1,097,319
-21% -$20.8M
EOSE icon
27
Eos Energy Enterprises
EOSE
$1.55B
$74.5M 0.89%
6,500,000
-3,800,000
-37% -$54.6M
COMP icon
28
Compass
COMP
$9.66B
$74M 0.88%
+7,000,000
New +$63.9M
ADEA icon
29
Adeia
ADEA
$3.12B
$73.9M 0.88%
4,284,205
– –
SPRY icon
30
ARS Pharmaceuticals
SPRY
$593M
$72.2M 0.86%
6,200,000
+1,700,000
+38% +$16.5M
COLL icon
31
Collegium Pharmaceutical
COLL
$844M
$69.3M 0.83%
1,496,436
-1,330,062
-47% -$55.6M
LBTYK icon
32
Liberty Global Class C
LBTYK
$3.47B
$67.6M 0.81%
6,121,582
+1,583,012
+35% +$17.6M
ENOV icon
33
Enovis
ENOV
$1.41B
$65.4M 0.78%
2,453,265
-296,735
-11% -$8.77M
SSYS icon
34
Stratasys
SSYS
$769M
$63.7M 0.76%
7,340,026
-463,071
-6% -$4.59M
ADM icon
35
Archer Daniels Midland
ADM
$38.6B
$63.3M 0.76%
+1,101,583
New +$65.8M
RNW icon
36
ReNew
RNW
$2.49B
$62.1M 0.74%
11,000,000
-3,438,061
-24% -$24.9M
BG icon
37
Bunge Global
BG
$21.4B
$60.3M 0.72%
676,510
+488,163
+259% +$45M
OPK icon
38
Opko Health
OPK
$1.04B
$60.2M 0.72%
47,791,243
– –
PRMB
39
Primo Brands
PRMB
$8.68B
$59.3M 0.71%
+3,628,815
New +$67.1M
PRLB icon
40
Protolabs
PRLB
$2.19B
$56.8M 0.68%
1,123,338
– –
OFIX icon
41
Orthofix Medical
OFIX
$424M
$56.4M 0.67%
3,721,715
– –
GEO icon
42
The GEO Group
GEO
$4.1B
$56.2M 0.67%
3,486,915
+500,000
+17% +$8.34M
ANDE icon
43
Andersons Inc
ANDE
$2.23B
$53.5M 0.64%
+1,005,631
New +$49.2M
MGTX icon
44
MeiraGTx Holdings
MGTX
$1.21B
$49.1M 0.59%
6,175,331
+2,448,880
+66% +$20.4M
MATV icon
45
Mativ Holdings
MATV
$685M
$48.4M 0.58%
3,982,442
– –
NWL icon
46
Newell Brands
NWL
$2.6B
$48.4M 0.58%
13,000,000
– –
TRVI icon
47
Trevi Therapeutics
TRVI
$2.52B
$47.2M 0.56%
3,766,749
-4,765,111
-56% -$55.1M
NRIX icon
48
Nurix Therapeutics
NRIX
$2.74B
$46.9M 0.56%
+2,473,885
New +$35.5M
MNKD icon
49
MannKind Corp
MNKD
$1.24B
$42.4M 0.51%
7,476,495
-3,938,176
-35% -$21.7M
HRTX icon
50
Heron Therapeutics
HRTX
$66M
$39.1M 0.47%
30,046,828
+946,100
+3% +$1.17M
1
2
3 4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return

Rubric Capital Management (New York)'s Q4 2025 Portfolio in Review

As of Q4 2025, Rubric Capital Management (New York) held 88 positions worth $8.36B, down 5.7% from $8.86B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Rubric Capital Management (New York) withdrew a net $840M in Q4 2025, closing 12 positions and reducing 17 holdings. Its most notable exit was Baxter International, an estimated $86M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Rubric Capital Management (New York) opened a new position in Vistra worth $323M.

  • Rubric Capital Management (New York)'s largest Q4 2025 buy was Vistra: 2,000,000 shares worth $323M.
  • Rubric Capital Management (New York) added most to Viatris in Q4 2025, an estimated $109M increase.
  • Rubric Capital Management (New York)'s biggest Q4 2025 reduction was Roivant Sciences, cutting an estimated $217M.
  • Rubric Capital Management (New York) fully exited Baxter International in Q4 2025, selling an estimated $86M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 55% of its $8.36B portfolio in Q4 2025.
  • Rubric Capital Management (New York) opened 16 new positions and closed 12 in Q4 2025.
  • Rubric Capital Management (New York)'s portfolio value fell 5.7% quarter-over-quarter to $8.36B.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.